Wall Street Bullish on China ETFs as the Rebound Gets Extreme
2022-12-05 00:00uSMART

Chinese stocks got a bullish nod from Wall Street after a strong rebound in November. Meanwhile, Wall Street is bullish on China ETFs as the rally got extreme.



  • China's stock market staged an epic rally in November, with the Hang Seng Index, Hengke Index, and China Golden Dragon Index jumping more than 20%, 30%, and 40% separately, all entering a technical bull market.
  • Citigroup, Bank of America, Morgan Stanley, and other big Wall Street firms are making speeches that “now is a good time to buy Chinese stocks”.
  • Foreign capital is swarming into a range of China-focused ETFs.


Best Performing Short China ETFs for November 2022
Ticker Name %Change
2800 Tracker Fund of Hong Kong 26.7%
3037 CSOP Hang Seng Index ETF 28.0%
3115 iShares Core Hang Seng Index ETF 27.3%
7200 CSOP Hang Seng Index Daily (2X) ETF 58.4%
3032 Hang Seng TECH Index ETF 35.6%
3033 CSOP Hang Seng TECH Index ETF 36.1%
3067 iShares Hang Seng TECH ETF 35.8%
7226 CSOP Hang Seng TECH Index Daily (2x) ETF 77.2%
KWEB KraneShares CSI China Internet ETF 55.5%
CWEB Direxion Daily CSI China Internet Bull 2X Shares 127.6%
PGJ Invesco Golden Dragon China ETF 46.6%
XPP ProShares Ultra FTSE China 50 77.9%
YINN Direxion Daily FTSE China Bull 3x Shares 131.7%
MCHI iShares MSCI China ETF 34.2%
FXI iShares China Large-Cap ETF 36.2%
ASHR Xtrackers Hvst CSI 300 China A-Shs ETF 17.7%



This article is intended for general circulation and educational purpose only and does not take into account of the specific investment objectives, financial situation or particular needs of any particular person. You should seek advice from a financial adviser regarding the suitability of the investment products mentioned. In the event you choose not to seek advice from a financial adviser, you should consider whether the investment product in question is suitable for you.

Past performance figures as well as any projection or forecast used in this article, are not necessarily indicative of future performance of any investment products. Your investment is subject to investment risk, including loss of income and capital invested. The value of the investment products and the income from them may fall or rise. No warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of this article. Overseas investments carry additional financial, regulatory and legal risks, you should do the necessary checks and research on the investment beforehand.

The information contained in this article has been obtained from public sources which the uSMART Securities (Singapore) Pte Ltd (“uSMART”) has no reason to believe are unreliable and any research, analysis, forecast, projections, expectations and opinion (collectively “Analysis”) contained in this article are based on such information and are expressions of belief only. uSMART has not verified this information and no representation or warranty, express or implied, is made that such information or Analysis is accurate, complete or verified or should be relied upon as such. Any such information or Analysis contained in this presentation is subject to change, and uSMART, its directors, officers or employees shall not have any responsibility for omission from this article and to maintain the information or Analysis made available or to supply any corrections, updates or releases in connection therewith. uSMART, its directors, officers or employees be liable for any or damages which you may suffer or incur as a result of relying upon anything stated or omitted from this article.

Views, opinions, and/or any strategies described in this article may not be suitable for all investors. Assessments, projections, estimates, opinions, views and strategies are subject to change without notice. This article may contain optimistic statements regarding future events or performance of the market and investment products. You should make your own independent assessment of the relevance, accuracy, and adequacy of the information contained in this article. Any reference to or discussion of investment products in this article is purely for illustrative purposes only, is not intended to constitute legal, tax, or investment advice of any investment products, and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products mentioned. This article does not create any legally binding obligations on uSMART. uSMART, its directors, connected persons, officers or employees may from time to time have an interest in the investment products mentioned in this article.